Aquilo Capital, L.P.'s Form 4 filing
Spero Therapeutics, Inc. (SPRO) · filed Sep 26, 2022
- Accession no.
- 0001591986-22-000018
- Filed
- Sep 26, 2022, 3:32 PM ET
- Trade date
- Sep 22, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.28M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Aquilo Capital, L.P.CIK 0001491371 | 10% Owner |
| Aquilo Capital Management, LLCCIK 0001591986 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 22, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −1,335,512 | $2.25 | −$3,005,302.65 | 3,985,719 | Indirect | |
| Sep 22, 2022 | Common Stock, $0.001 par value | SSaleDisposed | −566,284 | $2.25 | −$1,274,308.89 | 3,419,435 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.